Clinical Trials
8 articles
AI adoption in healthcare faces clinical implementation hurdles
While AI-enabled clinical trials promise to shorten timelines and reduce costs, the real challenge lies in integrating these advanced tools into the daily, complex workflows of hospitals and clinics.
FDA cleared AI devices lack patient outcome data
Despite over 520 AI medical devices receiving FDA marketing authorization since 2017, a recent systematic review found fewer than 6% have published prospective clinical trial data demonstrating patien
AI validation gap threatens emergency medicine decision support
A recent study revealed that 70% of AI-powered diagnostic tools approved for emergency use have not undergone prospective, multi-center clinical trials, raising alarms among medical professionals ( Jo
AI Advancements Revolutionizing Regenerative Medicine
Insilico Medicine's Rentosertib, an oral small-molecule inhibitor for idiopathic pulmonary fibrosis (IPF), progressed from discovery to a Phase III clinical trial in record time.
How AI is Accelerating Drug Discovery and Vaccine Development
In a remarkable acceleration, AI helped Insilico achieve a 30-month sprint from target identification to a Phase I clinical trial candidate, a process that traditionally takes years longer, according
How Nexus Scientific Solutions, LLC Uses NSSCertiTrial™ and Empirio™ to Simplify Clinical Research Operations
Nexus Scientific Solutions, LLC uses NSSCertiTrial™ and Empirio™ to simplify clinical research operations by providing a centralized platform for managing studies, participant workflows, and documentation. These products aim to replace fragmented, spreadsheet-dependent systems with organized research and clinical operations.
AI accelerates oncology trials, FDA shapes AI-driven research
A novel AI-generated TNIK inhibitor recently completed a Phase 2a trial for idiopathic pulmonary fibrosis, demonstrating AI's shift from data analysis to active therapeutic compound design.
How Machine Learning Speeds Drug Discovery in Clinical Trials
80% of clinical trials miss their timelines, imposing daily costs of up to $8 million on pharmaceutical companies, according to Nature .